The SLC4A family includes several well-characterized members, such as SLC4A1 (AE1, anion exchanger 1), SLC4A2 (band 3 protein), SLC4A3 (AE2), SLC4A4 (NBCe1, sodium-bicarbonate cotransporter 1), and SLC4A7 (NBCn1, sodium-bicarbonate cotransporter, Na⁺-dependent). AE1, encoded by SLC4A1, is primarily expressed in red blood cells, where it facilitates the exchange of chloride and bicarbonate ions, aiding in CO₂ transport and pH homeostasis. Mutations in SLC4A1 are associated with hereditary spherocytosis and distal renal tubular acidosis (dRTA).
SLC4A2, another anion exchanger, is widely expressed in various tissues, including the kidney, brain, and placenta, contributing to ion transport and cellular pH regulation. SLC4A3 (AE2) is predominantly found in epithelial cells, particularly in the stomach and kidneys, where it helps regulate acid secretion and bicarbonate reabsorption. Mutations in SLC4A3 have been linked to gastric acid hypersecretion and metabolic alkalosis.
SLC4A4 encodes NBCe1, a sodium-bicarbonate cotransporter that mediates the uptake of bicarbonate into cells in response to intracellular acidification. This protein is crucial for maintaining cellular pH in various tissues, including the brain, pancreas, and kidneys. Dysfunction in NBCe1 has been implicated in neurological disorders and metabolic disturbances.
SLC4A7 encodes NBCn1, a sodium-bicarbonate cotransporter that operates in neurons and other excitable cells, playing a role in synaptic transmission and neuronal excitability. Mutations in SLC4A7 have been associated with neurological conditions, including epilepsy and developmental disorders.
The SLC4A family proteins are structurally related, featuring 12–14 transmembrane domains and a large cytoplasmic loop containing regulatory sites. Their activity is often modulated by intracellular pH, phosphorylation, and interaction with other proteins. Understanding the function of these transporters is vital for elucidating their roles in health and disease, as well as for developing therapeutic strategies targeting related disorders.